Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb 13;79(4):102.
doi: 10.1007/s00284-022-02767-y.

Antimicrobial Peptides as a Promising Therapeutic Strategy for Neisseria Infections

Parvin Askari  1 , Masoud Yousefi  2 , Mohsen Foadoddini  3 , Alireza Neshani  4   5   6 , Mahdi Aganj  4   6   7 , Nasim Lotfi  8 , Aref Movaqar  4   6 , Kiarash Ghazvini  9   10 , Mohammad Hasan Namaei  11
Affiliations
Review

Antimicrobial Peptides as a Promising Therapeutic Strategy for Neisseria Infections

Parvin Askari et al. Curr Microbiol. .

Abstract

Antibiotic resistance is already widespread in the world, and it has become a great health problem. Therefore, comprehensive efforts are needed to minimize the resistance. The exploration of alternative therapies may offer a more targeted approach with less susceptibility to resistance. Even though antimicrobial peptides (AMPs) have been introduced as emerging antibiotic sources, they are not widely discussed in the literature. Since Neisseria infections show resistance to different types of antibiotics, the purpose of this review was to discuss the currently investigated AMPs with anti-Neisseria properties. In the present review, we provide an overview of 24 AMPs with in vitro anti-Neisseria properties.

PubMed Disclaimer

References

    1. Lenz JD, Dillard JP (2018) Pathogenesis of Neisseria gonorrhoeae and the host defense in ascending infections of human fallopian tube. Front Immunol 9:2710 - PubMed - PMC
    1. Jen FE-C, Semchenko EA, Day CJ, Seib KL, Jennings MP (2019) The Neisseria gonorrhoeae methionine sulfoxide reductase (MsrA/B) is a surface exposed, immunogenic, vaccine candidate. Front Immunol 10:137 - PubMed - PMC
    1. Unemo M, Shafer WM (2011) Antibiotic resistance in Neisseria gonorrhoeae: origin, evolution, and lessons learned for the future. Ann N Y Acad Sci 1230:E19 - PubMed - PMC
    1. Vyse A, Wolter J, Chen J, Ng T, Soriano-Gabarro M (2011) Meningococcal disease in Asia: an under-recognized public health burden. Epidemiol Infect 139(7):967–985 - PubMed
    1. Bala M, Sood S (2010) Cephalosporin resistance in Neisseria gonorrhoeae. J Glob Infect Dis 2(3):284 - PubMed - PMC

MeSH terms

Substances

LinkOut - more resources